- Home
- BOLT vs TNMG Comparison
BOLT vs TNMG Comparison
Compare BOLT & TNMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- TNMG
- Stock Information
- Founded
- BOLT 2015
- TNMG 2023
- Country
- BOLT United States
- TNMG Japan
- Employees
- BOLT N/A
- TNMG N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- TNMG
- Sector
- BOLT Health Care
- TNMG
- Exchange
- BOLT Nasdaq
- TNMG NYSE
- Market Cap
- BOLT 16.8M
- TNMG 16.9M
- IPO Year
- BOLT 2021
- TNMG N/A
- Fundamental
- Price
- BOLT $0.31
- TNMG $0.57
- Analyst Decision
- BOLT Buy
- TNMG
- Analyst Count
- BOLT 3
- TNMG 0
- Target Price
- BOLT $2.50
- TNMG N/A
- AVG Volume (30 Days)
- BOLT 768.8K
- TNMG 9.8M
- Earning Date
- BOLT 05-12-2025
- TNMG 08-01-2025
- Dividend Yield
- BOLT N/A
- TNMG N/A
- EPS Growth
- BOLT N/A
- TNMG N/A
- EPS
- BOLT N/A
- TNMG N/A
- Revenue
- BOLT $3,638,000.00
- TNMG $48,493,897.00
- Revenue This Year
- BOLT N/A
- TNMG N/A
- Revenue Next Year
- BOLT $97.29
- TNMG N/A
- P/E Ratio
- BOLT N/A
- TNMG N/A
- Revenue Growth
- BOLT N/A
- TNMG 35.31
- 52 Week Low
- BOLT $0.28
- TNMG $0.26
- 52 Week High
- BOLT $0.78
- TNMG $34.08
- Technical
- Relative Strength Index (RSI)
- BOLT 35.02
- TNMG N/A
- Support Level
- BOLT $0.29
- TNMG N/A
- Resistance Level
- BOLT $0.33
- TNMG N/A
- Average True Range (ATR)
- BOLT 0.04
- TNMG 0.00
- MACD
- BOLT -0.00
- TNMG 0.00
- Stochastic Oscillator
- BOLT 5.45
- TNMG 0.00
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About TNMG TNL MEDIAGENE
TNL Mediagene is principally engaged in digital advertising, integrated marketing, marketing survey, artificial intelligence technology, data analysis, content service platform and production of audio-visual programs. Geographically, the company generates the majority of its revenue from Taiwan.